Notícias

Gene-editing biotech debuts at $25, backed by Sanofi and Eli Lilly, with a roughly $440.3 million valuation.

South-Korea memory-chip maker SK Hynix stock offers its first buy point ahead of the firm's debut earnings report next week.

Federal AI contracts are pouring into enterprise software order books, and two of the sector's most beaten-down stocks are suddenly surging. Whether today's rally marks a genuine turning point or a fleeting squeeze depends on details buried inside fresh earnings reports and a blockbuster government deal.

HUM enters Q2 earnings with strong premium and membership growth expectations, but rising medical costs and expenses could test its bottom line.

Sensata (ST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

(Bloomberg) -- Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, surged 67% on Friday after raising $128.7 million in an upsized initial public offering.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesSpaceX Turns Away Falcon Customers in Majo

Eli Lilly stock hit an all-time high of 1,249.50 before pulling back into a buy zone above a pivot of 1,133.95.

HOG beats Q2 earnings estimates as motorcycle demand lifts HDMC, while HDFS revenues plunge and LiveWire narrows losses.

NextEra Energy reported another strong quarter.

Ford faces lower Q2 sales and EV weakness, but cost controls, product mix and valuation support its long-term case as investors await clearer guidance.

Intel stock (INTC), which initially surged following its second quarter earnings yesterday, is trying to hold onto some of its gains Friday morning. Morning Brief Host Julie Hyman is joined by Yahoo Finance Senior Business Reporter Ines Ferré and Interactive Brokers chief strategist Steve Sosnick to discuss Intel's earnings release, outlook, and performance of its various business segments.

American Express (NYSE:AXP) stock is sliding Friday morning, trading at $320.55 and down 6% after the card issuer reported a Q2 2026 beat that traders opted to fade. The reaction hit within an hour of the 8:30 a.m. ET 8-K Form, pulling American Express stock down from a prior close of $340.84. The drop extends ... American Express Sinks 6% After Q2 Earnings Beat as Visa, Mastercard Hold Steady

RTX tops Q2 earnings estimates and boosts full-year 2026 outlook as commercial aerospace, defense demand, and a record backlog fuel strong growth.

The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s OTTAVA Robotic Surgical System, marking the regulatory clearance of the world’s first table-integrated soft tissue robotic platform. The marketing clearance encompasses multiple general surgery...

Intel's stock is surging while the rest of the chip sector sits flat, and the reasons behind that split tell a much bigger story about where the semiconductor race is actually headed.

UiPath's stock has been left for dead, yet several of enterprise software's biggest players have compelling reasons to want it. Five names stand out as potential acquirers, and the logic behind one of them is almost impossible to argue against.

Strong demand prompts higher spending despite ongoing supply constraints

Investing.com -- The recent pullback in semiconductor stocks, driven by surging oil prices, rising bond yields and concerns over AI spending, represents a buying opportunity for the sector, Citi analysts say.

NextEra (NEE) delivered earnings and revenue surprises of +5.51% and -5.76%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Verizon Communications Inc. (NYSE:VZ) shares rose 2.

Oracle Powers Higher After Landing Potential $7 Billion Federal Contract

(Bloomberg) -- Corporate earnings strong enough to beat the highest expectations in years have failed to impress investors fretting about AI spending and economic growth.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesAlphabet Falls as $205 Billion Spending Plan Fuels AI Cost FearAbo

SLB (SLB) delivered earnings and revenue surprises of +7.84% and +2.95%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Verizon topped Q2 earnings estimates and added more "postpaid" phone subscribers than expected. But revenue fell short.

The card company posted second-quarter earnings of $4.53 per share, up 11% from a year ago, as card member spending rose 9%

The wireless carrier added 184,000 postpaid phone net subscribers in the second quarter, well above analyst forecasts

SLB posts better-than-expected earnings as demand for its oilfield services increases outside the Middle East.

Investing.com -- Verizon Communications Inc (NYSE:VZ) on Friday reported second quarter results that exceeded adjusted earnings expectations while revenue fell short of analyst estimates, with shares rising 2.7% following the announcement.

Investing.com -- SLB on Friday reported second-quarter adjusted earnings per share of $0.55, beating the analyst consensus of $0.51 by $0.04, as revenue of $8.97 billion exceeded expectations of $8.67 billion.

Oilfield services provider SLB (NYSE:SLB) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 4.5% year on year to $8.97 billion. Its non-GAAP profit of $0.55 per share was 6.1% above analysts’ consensus estimates.